AGMB
AgomAb Therapeutics NV
8.60$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +25.9% | -177.6% | – | |
| – | +168.1% | +6.1% | -64.9% | |
| – | – | +978.7% | -218.4% | |
| – | -100.0% | – | +8,975.0% | |
| – | – | – | -98.8% | |
| – | +147.6% | -78.2% | – | |
| – | -100.2% | -78.2% | – | |
| – | -120.0% | – | – | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.